Device / Technology News

RSS

New Purdue biochip may speed drug development

Purdue University researchers have developed a biochip that measures the electrical activities of cells and is capable of obtaining 60 times more data in just one reading than is possible with current technology.

20 Oct 2006

DNA-based computer that could lead to faster West Nile virus detection

New technique detects signature of metastasizing melanoma with as few as 10 cancer cells present in blood sample.

16 Oct 2006

Lab-on-a-chip technology for determination of protein isoform profiles

A new microfluidics device that uses immobilized antibodies and carbon nanostrings as detection agents can identify slight variations in protein composition, known as protein isoforms, that could indicate the presence of cancer.

16 Oct 2006

FDA approves test to help diagnose HIV

The U.S. Food and Drug Administration (FDA) has approved the APTIMA HIV-1 RNA Qualitative Assay, manufactured by Gen-Probe Incorporated (San Diego, Calif.).

5 Oct 2006

Laser technique shows women's skin ages faster than men's

According to German researchers women's skin ages faster than men's - so men become distinguished women just look older!

4 Oct 2006

Advanced Neuromodulation Systems receives Australian approval for rechargeable chronic pain system

Advanced Neuromodulation Systems (ANS), the neuromodulation business of St. Jude Medical, Inc, today announced Australian Therapeutic Goods Administration (TGA) regulatory approval for its Eon Rechargeable Neurostimulation System.

3 Oct 2006

Sunshine Heart awarded $2.15m grant to support development of heart assist device

Sunshine Heart, Inc., today announced it has been awarded a second Commercial Ready Grant (CRG) from the Australian Government to help fund further development of its revolutionary C-Pulse heart assist device.

21 Sep 2006

Uroplasty receives FDA approvable letter for treatment of female stress urinary incontinence

Uroplasty, Inc. has announced that it has received an approvable letter from the U.S. Food and Drug Administration (FDA) relating to its pre-market approval (PMA) application for Macroplastique Implants for the treatment of female stress urinary incontinence (SUI).

14 Sep 2006

MIT device to detect and prevent epileptic seizures

Epilepsy affects about 50 million people worldwide, and while anticonvulsant medications can reduce the frequency of seizures, the drugs are ineffective for as many as one in three patients.

12 Sep 2006

New wireless internet technologies could reduce physician visits for patients with chronic diseases

The New York Times on Saturday examined new technologies that will allow tens of millions of U.S. residents with chronic diseases such as heart failure, diabetes and mental illnesses to have their conditions "constantly monitored, remotely and virtually, as they go about their daily lives."

11 Sep 2006

New device may reduce complications during heart surgery

Recycling of fat-contaminated blood from the wound during heart surgery, is suspected to contribute to enhance the risk of post-surgical brain damage.

11 Sep 2006

FDA releases draft guidelines regulating complex diagnostic tests

FDA on Tuesday released draft guidelines that assert the agency's authority for regulating gene- and protein-based diagnostic tests for conditions such as breast cancer and ovarian cancer, the Wall Street Journal reports.

6 Sep 2006

First drug-eluting stent approved in Europe for most severe form of arterial disease in the leg

Cordis Endovascular, a division of Cordis Corporation, announced today that the Cypher Select Sirolimus-eluting stent received CE (Communite European) Mark in Europe for use in the treatment of severe claudication and critical limb ischemia (CLI) of infrapopliteal lesions, which is the most severe form of arterial disease in the leg.

6 Sep 2006

FDA approves limited use of artificial heart

The Food and Drug Administration (FDA) in the United States has given approval for limited use of an artificial heart.

6 Sep 2006

FDA provides guidance to industry for active ingredients used in medical tests

The U.S. Food and Drug Administration (FDA) today issued draft regulatory guidance for the medical device industry on commercially distributed active ingredients of medical tests called Analyte Specific Reagents (ASRs).

5 Sep 2006

FDA approves AbioCor permanent artificial heart for humanitarian uses

The U.S. Food and Drug Administration today approved the first totally implanted artificial heart for patients with advanced heart failure involving both pumping chambers of the heart under the Humanitarian Use Device (HUD) provisions of the Food, Drug and Cosmetic Act.

5 Sep 2006

FDA drafts new guidance to industry for group of medical tests

The U.S. Food and Drug Administration (FDA) today issued draft regulatory guidance for industry and clinical laboratories for a new type of medical test.

5 Sep 2006

New York Times examines debate over preimplantation genetic diagnosis

The New York Times on Sunday examined the debate over preimplantation genetic diagnosis, a technique that allows physicians to identify embryos without genetic defects or chromosomal abnormalities and then implant the embryos most likely to result in a live, healthy infant.

5 Sep 2006

New microfluidic device suitable for large-scale screening of disease-related biomarkers

Researchers at the Virginia Bioinformatics Institute (VBI) at Virginia Tech have developed a disposable microchip that replaces space-consuming instrumentation with fast, cost-effective, lab-on-a-chip technology.

5 Sep 2006

New technology can help a tired heart

World Congress of Cardiology Report - We have shown that it is possible to care for ill patients affected by heart failure directly from home by controlling their heart rate, fluid retention, blood pressure and weight through new telemedicine techniques.

5 Sep 2006